Stock LDX LUMOS DIAGNOSTICS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.055 AUD -3.51% Intraday chart for Lumos Diagnostics Holdings Limited -1.79% -24.66%
Apr. 09 Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows MT
Feb. 27 Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2022 2023
Capitalization 1 20.27 2.267
Enterprise Value (EV) 2 19.48 9.037
P/E ratio -0.32 x -0.19 x
Yield - -
Capitalization / Revenue 1.74 x 0.22 x
EV / Revenue 1.68 x 0.86 x
EV / EBITDA -0.76 x -1 x
EV / FCF -623,671 x -1,245,705 x
FCF Yield -0% -0%
Price to Book 1.13 x 0.24 x
Nbr of stocks (in thousands) 209,906 309,420
Reference price 3 0.0965 0.007326
Announcement Date 8/25/22 8/29/23
1USD in Million2AUD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Junio 2018 2019 2020 2021 2022 2023
Net sales 1 2.594 6.382 8.396 25.06 11.63 10.54
EBITDA 1 -1.66 -3.93 -12.51 -14.42 -25.65 -9.074
EBIT 1 -1.739 -4.113 -12.81 -14.82 -26.88 -10.24
Operating Margin -67.04% -64.45% -152.58% -59.16% -231.17% -97.16%
Earnings before Tax (EBT) 1 -1.711 -7.416 -13.53 -20.13 -45.72 -8.971
Net income 1 -1.711 -6.546 -13.45 -20.13 -45.72 -8.971
Net margin -65.98% -102.57% -160.15% -80.33% -393.16% -85.15%
EPS - -0.3878 -0.5171 -0.1340 -0.3002 -0.0382
Free Cash Flow - -3.794 -16.44 0.4625 -31.24 -7.254
FCF margin - -59.45% -195.81% 1.85% -268.58% -68.86%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/16/20 12/16/20 12/16/20 8/29/21 8/25/22 8/29/23
1AUD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 S2 2022 S1 2022 S2 2023 S1
Net sales 13.44 7.201 9.231 -
EBITDA -15.23 -12.54 - -
EBIT -11.34 -14.06 -15.68 -
Operating Margin -84.34% -195.23% -169.84% -
Earnings before Tax (EBT) - - - -
Net income 1 - - -49.74 -9.748
Net margin - - -538.83% -
EPS 2 - - - -0.0465
Dividend per Share - - - -
Announcement Date 8/29/21 2/27/22 8/25/22 2/26/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 6.61 10.5 4.72 - - 6.77
Net Cash position 1 - - - 49.1 0.78 -
Leverage (Debt/EBITDA) -3.98 x -2.667 x -0.3774 x - - -0.7461 x
Free Cash Flow - -3.79 -16.4 0.46 -31.2 -7.25
ROE (net income / shareholders' equity) - -63.4% -55.2% -36.6% -120% -65.5%
ROA (Net income/ Total Assets) - -10.7% -20% -10.6% -24.9% -20.5%
Assets 1 - 61.36 67.23 189.5 183.6 43.72
Book Value Per Share - 0.9800 0.1800 0.5200 0.0900 0.0300
Cash Flow per Share - 0.2600 0.0500 0.4000 0.0400 0.0100
Capex 1 2.27 3.6 9.45 13.7 2.52 0.13
Capex / Sales 87.71% 56.43% 112.5% 54.86% 21.69% 1.19%
Announcement Date 12/16/20 12/16/20 12/16/20 8/29/21 8/25/22 8/29/23
1AUD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
LUMOS DIAGNOSTICS HOLDINGS LIMITED Stock Lumos Diagnostics Holdings Limited
-24.66% 17.26M
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-10.29% 7.61B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.16% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+5.74% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.70% 3.3B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+12.21% 2.73B
VITROLIFE AB Stock Vitrolife AB
-16.13% 2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-11.50% 1.73B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
-5.02% 1.64B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. LDX Stock
  4. Financials Lumos Diagnostics Holdings Limited